Mission: To improve the lives of patients by resolving diagnostic uncertainty and reducing risky, costly and often unnecessary surgeries.
We’re proud to announce that we’ve been named a Bay Area Top Workplace for the fourth year in a row! A big thank you to our employees who helped make this happen – and who are helping us fundamentally improve patient care every day!
Congrats to @BonnieAndDx, our fantastic CEO, who’s been named one of @FierceBiotech's “2017 Fiercest Women in Life Sciences.” She’s a great inspiration to all women in the field. http://glassdoor.com/slink.htm?key=vQLBk.
Veracyte is a pioneering genomic diagnostics company. Our tests are dramatically improving clinical outcomes for patients by resolving inconclusive results from traditional diagnostic methods. We ask the right questions to resolve ambiguity and bring assurance to light, rendering tens of thousands of costly and unnecessary surgeries truly unnecessary. We are giving patients a clearer path forward.
Through scientific rigor we employ the best tools, best science and best minds to create tests that enable a more accurate diagnosis without the need for risky, costly and often unnecessary surgery. Veracyte consistently brings to bear evidence that is unprecedented in genomic tests, thereby changing today's clinical practice standards. We are making a difference in the lives of physicians and patients. We are doing something real.
Veracyte’s pioneering genomic tests are already setting new standards in thyroid and lung cancer diagnosis, where they have helped tens of thousands of patients avoid unnecessary surgery and other costly procedures. In late 2016, we launched our third product—the Envisia Genomic Classifier—to improve diagnosis of interstitial lung diseases, including idiopathic pulmonary fibrosis, without the need for surgery.
Bonnie H. Anderson is Chairman of the Board, President and Chief Executive Officer of Veracyte. Her career spans over 30 years in regulated diagnostics and life science markets. Ms. Anderson cofounded Veracyte in 2008, took the company public in 2013 and has spearheaded Veracyte’s commercialization successes to date. Prior to Veracyte, Ms. Anderson provided strategic consulting services to venture capital firms and early-stage businesses following 18 years in leadership positions at Beckman Coulter. She serves on the board of Castle Biosciences and on the steering committee for the Coalition for 21st Century Medicine and is a trustee emeritus of the Keck Graduate Institute of Applied Life Sciences. She graduated from Indiana University of Pennsylvania with a Bachelors of Science degree in Medical Technology and in 2012 was honored with a “Distinguished Alumni” award. In 2015, Fast Company magazine named Ms. Anderson to its “100 Most Creative People in Business” list. She was named one of the “Most Influential Women in Bay Area Business” (2013) and one of the “Bay Area’s Most Admired CEOs” (2014) by the San Francisco Business Times, and has also received the Silicon Valley Business Journal’s “Women of Influence” award (2013).
At Veracyte we are redefining diagnostic truth and changing patient care as we know it. Our tests are improving the lives of patients, providing them with a clear path forward. We, in our various roles at Veracyte, are doing something REAL.
We embrace challenges—the more complex, the better. We are laser-focused and know how to prioritize. We actwith a sense of urgency, because when it comes to advancing patient care, every minute matters. We take ownership of our work and are deeply committed to the success of our team. And, above all, we value integrity—in our work and how we treat all our stakeholders, including each other.
We are a growing company and each member of our team is crucial to our success and to helping to shape the future of our company.
I have been working at Veracyte full-time
Everyone is working hard and supporting each other, it's the kind of place where you want to go to work in the morning! It's not always easy in healthcare to find research and products you really believe in, but Veracyte has that and has employees that care about patient impact. Management is relaxed but supportive when you need resources. Pay is competitive. Company maintains intimate feel while still expanding a lot. All around great!
PTO and benefits are reasonable, but could be better as compared to other biotech companies nearby.
The interview process was standard. I applied online and they conducted a phone interview with basic interview questions. I was asked to come in for an in-person interview. It lasted about two hours, and the consisted of several small rotating groups, one of which was just the hiring manager who asked my questions from a printed document and wrote down my answers. The atmosphere of the office seemed quiet and sad, and the workers also seemed to have a lack of company culture. I was told that I was a favorite by the person who walked me out and that I would be contacted within the week, and I never heard anything even after I inquired a week later with the hiring manager. There are better bio-tech companies out there, and I do not suggest this one.